Oncology Resource Group

Oncology Competitive Intelligence Leaders

News

Oncology Experts: A Central Source for Insights and Strategic Analysis

Featured Story

September 30, 2026Regina Cheung, Ph.D., Patrick Nygren, Ph.D. and Jillian R. James

The 2026 ESMO LBA Landscape: Visualized

Which mechanisms are commanding the late-breaker spotlight this year? Our analysts crunched the numbers across all LBAs: ADCs lead the field — nearly a third of all LBA drugs, spanning NSCLC, breast, ovarian, and beyond.

  • SCLC
  • ADCs
  • Lung
  • +4

    Sample Request

    How Did You Hear About Us